The Australian Dollar is currently the fifth-most-traded currency in world foreign exchange markets. It is also used in the Christmas Island, Cocos (Keeling) Islands, and Norfolk Island, as well as the independent Pacific Island states of Kiribati, Nauru and Tuvalu.
Friday, November 15, 2013
[News & Analysis] Infectious Disease: Israel's Silent Polio Epidemic Breaks All the Rules
Science 8 November 2013:
Vol. 342 no. 6159 pp. 679-680
DOI: 10.1126/science.342.6159.679 Infectious Disease Twenty-five years after it was dispatched, wild poliovirus is back and circulating widely in Israel but, surprisingly, there have been no cases. Like many other wealthy countries, Israel relies on the inactivated polio vaccine, or IPV, to protect against this crippling disease. Paradoxically, Israel's very high vaccination rate is what has allowed the virus to circulate silently for months.
Thursday, November 14, 2013
[News & Analysis] Paleontology: The Ears Have It: First Snakes Were Burrowers, Not Swimmers
Science 8 November 2013:
Vol. 342 no. 6159 p. 683
DOI: 10.1126/science.342.6159.683-a Paleontology One of paleontology's sharpest debates concerns whether the first snakes crawled on land or swam in the water. Data on the inner ear anatomy of living and fossil snakes, presented at a recent meeting, suggest that snakes evolved from terrestrial, burrowing ancestors.
[News & Analysis] Intellectual Property: California Moves Shake Up Prenatal Gene Testing Market
Science 8 November 2013:
Vol. 342 no. 6159 p. 680
DOI: 10.1126/science.342.6159.680 Intellectual Property Sequenom's 2001 patent on a method of isolating fetal DNA from a mother's bloodstream to test for Down syndrome was thrown out by a U.S. court in San Francisco. Judge Susan Illston rested her decision in part on the recent Supreme Court ruling that natural phenomena like genes cannot be patented. Illston also wrote that Sequenom's patented idea was not sufficiently inventive.
Wednesday, November 13, 2013
[News Focus] Malaria as Lifesaving Therapy
Science 8 November 2013:
Vol. 342 no. 6159 p. 686
DOI: 10.1126/science.342.6159.686 Vivax malaria was once familiar to doctors not only as a foe, but also as an ally. In the first half of the 20th century, it was used to treat tens of thousands of patients suffering from end-stage syphilis, who were otherwise doomed to a gruesome death. The treatment, seen as a miracle cure, did allow many to recover, and its discoverer won a Nobel Prize.
Subscribe to:
Posts (Atom)